{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:30:33Z","timestamp":1760229033596,"version":"build-2065373602"},"reference-count":88,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Reports"],"abstract":"<jats:p>Recent studies identified pregnancy as a high-risk condition for the development of maternal-fetal complications in the case of the SARS-CoV-2 infection. Therefore, the scientific community is now considering pregnant women a \u201cfragile\u201d category that should be vaccinated with high priority. The number of pregnant women undergoing hospitalization since summer 2021, including Intensive Care Unit admission, is growing, as well as the risk of preterm birth. Evidence from both animals and humans suggest that, similarly to other vaccines routinely administered in pregnancy, COVID-19 vaccines are not crossing the placenta, do not increase the risk of miscarriage, preterm birth, stillbirth, the birth of small gestational age neonates, as well as the risk of congenital abnormalities. To date, the World Health Organization and scientific literature are promoting and encouraging the vaccination of all pregnant and lactating women. The aim of our narrative review is to present the available literature regarding this issue with the aim to provide appropriate answers to the most frequent requests, doubts, and fears that have led many expecting and lactating women not to become vaccinated during this pandemic period.<\/jats:p>","DOI":"10.3390\/pediatric14020034","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:25:12Z","timestamp":1653956712000},"page":"262-275","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["What to Expect from COVID-19 and from COVID-19 Vaccine for Expecting or Lactating Women"],"prefix":"10.3390","volume":"14","author":[{"given":"Roberta","family":"Gangi","sequence":"first","affiliation":[{"name":"School of Pediatrics, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Corrias","sequence":"additional","affiliation":[{"name":"School of Pediatrics, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-0310","authenticated-orcid":false,"given":"Roberta","family":"Pintus","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Cagliari and Neonatal Intensive Care Unit, AOU di Cagliari, 09124 Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Marcialis","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Cagliari and Neonatal Intensive Care Unit, AOU di Cagliari, 09124 Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Fanos","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Cagliari and Neonatal Intensive Care Unit, AOU di Cagliari, 09124 Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/AOG.0b013e3181d57947","article-title":"Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women","volume":"115","author":"Creanga","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3201\/eid1602.091733","article-title":"Perinatal pandemic (H1N1) 2009 infection, Thailand","volume":"16","author":"Dulyachai","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/cid\/ciq012","article-title":"Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009\u2013April 2010)","volume":"52","author":"Shrestha","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.vaccine.2016.12.012","article-title":"Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies","volume":"35","author":"Mertz","year":"2017","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mertz, D., Lo, C.K., Lytvyn, L., Ortiz, J.R., and Loeb, M. (2019). Flurisk-Investigators. Pregnancy as a risk factor for severe influenza infection: An individual participant data meta-analysis. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4318-3"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"CDC (2020). COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)\u2014United States, February 12-March 16, 2020. MMWR Morb. Mortal. Wkly. Rep., 69, 343\u2013346.","DOI":"10.15585\/mmwr.mm6912e2"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.23628","article-title":"Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy","volume":"57","author":"Buca","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Donders, G.G.G., Grinceviciene, S., Haldre, K., Lonnee-Hoffmann, R., Donders, F., Tsiakalos, A., Adriaanse, A., Martinez de Oliveira, J., Ault, K., and Mendling, W. (2021). ISIDOG Consensus Guidelines on COVID-19 Vaccination for Women before, during and after Pregnancy. J. Clin. Med., 10.","DOI":"10.20944\/preprints202104.0530.v1"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/aogs.13901","article-title":"Public Health Agency of Sweden\u2019s Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden","volume":"99","author":"Collin","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.15585\/mmwr.mm6938e1","article-title":"Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19\u2014COVID-NET, 13 States, 1 March\u201322 August 2020","volume":"69","author":"Delahoy","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Khan, D.S.A., Pirzada, A.N., Ali, A., Salam, R.A., Das, J.K., and Lassi, Z.S. (2021). The Differences in Clinical Presentation, Management, and Prognosis of Laboratory-Confirmed COVID-19 between Pregnant and Non-Pregnant Women: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18115613"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e211050","DOI":"10.1001\/jamapediatrics.2021.1050","article-title":"Maternal and Neonatal Morbidity and Mortality Among Pregnant Women with and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study","volume":"175","author":"Villar","year":"2021","journal-title":"JAMA Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"m3320","DOI":"10.1136\/bmj.m3320","article-title":"For PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status\u2014United States, 22 January\u20133 October 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.2147\/IDR.S325496","article-title":"A Comprehensive Review of the Management of Pregnant Women with COVID-19: Useful Information for Obstetricians","volume":"14","author":"Guo","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"77.e1","DOI":"10.1016\/j.ajog.2020.12.1221","article-title":"Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State","volume":"225","author":"Lokken","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijgo.13329","article-title":"Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review","volume":"151","author":"Turan","year":"2020","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_18","unstructured":"ItOSS (2020, July 31). Sorveglianza Ostetrica Vaccinazione Contro il COVID-19 in Gravidanza e Allattamento. Available online: https:\/\/www.epicentro.iss.it\/itoss\/aggiornamenti."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0140-6736(21)00716-9","article-title":"Were pregnant women more affected by COVID-19 in the second wave of the pandemic?","volume":"397","author":"Kadiwar","year":"2021","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Vousden, N., Ramakrishnan, R., Bunch, K., Morris, E., Simpson, N., Gale, C., O\u2019Brien, P., Quigley, M., Brocklehurst, P., and Kurinczuk, J.J. Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: Data from the UK Obstetric Surveillance System national cohort. medRxiv, 2021.","DOI":"10.1101\/2021.07.22.21261000"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/jpm-2020-0409","article-title":"A considerable asymptomatic proportion and thromboembolism risk of pregnant women with COVID-19 infection in Wuhan, China","volume":"49","author":"Wang","year":"2020","journal-title":"J. Perinat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Vousden, N., Bunch, K., Morris, E., Simpson, N., Gale, C., O\u2019Brien, P., Quigley, M., Brocklehurst, P., Kurinczuk, J.J., and Knight, M. (2021). The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251123"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.1038\/s41598-021-86452-3","article-title":"Symptoms and syndromes associated with SARS-CoV-2 infection and severity in pregnant women from two community cohorts","volume":"11","author":"Molteni","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.accpm.2020.05.003","article-title":"Coagulation changes and thromboembolic risk in COVID-19 obstetric patients","volume":"39","author":"Benhamou","year":"2020","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/AOG.0000000000004339","article-title":"Disease Severity and Perinatal Outcomes of Pregnant Patients with Coronavirus Disease 2019 (COVID-19)","volume":"137","author":"Metz","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0037-1602375","article-title":"Pulmonary Infections in Pregnancy","volume":"38","author":"Mathad","year":"2017","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1080\/14767058.2020.1771692","article-title":"Relationship between pregnancy and coronavirus: What we know","volume":"35","author":"Forestieri","year":"2020","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"ref_28","first-page":"8868822","article-title":"A Case Series on Critically Ill Pregnant or Newly Delivered Patients with COVID-19, Treated at Karolinska University Hospital, Stockholm","volume":"2021","author":"Polcer","year":"2021","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"391.e1","DOI":"10.1016\/j.ajog.2020.10.005","article-title":"Coronavirus disease 2019 and first-trimester spontaneous abortion: A case-control study of 225 pregnant patients","volume":"224","author":"Cosma","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/AOG.0000000000004010","article-title":"Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review","volume":"136","author":"Huntley","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/jog.14321","article-title":"Clinical update on COVID-19 in pregnancy: A review article","volume":"46","author":"Ryan","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ajcp\/aqaa089","article-title":"Placental Pathology in COVID-19","volume":"154","author":"Shanes","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajog.2020.07.049","article-title":"Vertical transmission of coronavirus disease 2019: A systematic review and meta-analysis","volume":"224","author":"Kotlyar","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/uog.22045","article-title":"Intrauterine vertical transmission of SARS-CoV-2: What we know so far","volume":"55","author":"Wang","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e2030455","DOI":"10.1001\/jamanetworkopen.2020.30455","article-title":"Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic","volume":"3","author":"Edlow","year":"2020","journal-title":"JAMA Netw. Open."},{"key":"ref_36","first-page":"ciaa1411","article-title":"Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study","volume":"73","author":"Flaherman","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pedneo.2020.10.001","article-title":"Characterization of neonates born to mothers with SARS-CoV-2 infection: Review and meta-analysis","volume":"J62","author":"Neef","year":"2021","journal-title":"Pediatr. Neonatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e58716","DOI":"10.7554\/eLife.58716","article-title":"Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?","volume":"9","author":"Romero","year":"2020","journal-title":"Elife"},{"key":"ref_39","first-page":"1848","article-title":"Antibodies in Infants Born to Mothers With COVID-19 Pneumonia","volume":"323","author":"Zeng","year":"2020","journal-title":"JAMA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.14477","article-title":"Transmission of SARS-CoV-2 through breast milk and breastfeeding: A living systematic review","volume":"1484","author":"Finkelstein","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.2020.15580","article-title":"Evaluation for SARS-CoV-2 in Breast Milk from 18 Infected Women","volume":"324","author":"Chambers","year":"2020","journal-title":"JAMA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/148.5.775","article-title":"Viral respiratory disease at Lowry Air Force Base in Denver, 1952\u20131982","volume":"148","author":"Meiklejohn","year":"1983","journal-title":"J. Infect. Dis."},{"key":"ref_43","unstructured":"Australian Tecnical Advisory Group of Immunisation (ATAGI) (2020, July 30). ATAGI Clinical Advice for Immunisation Providers Regarding Maternal Vaccination through the National Immunisation Program (NIP) 25 June 2018, Available online: https:\/\/www.health.gov.au\/resources\/publications\/atagi-clinical-advice-for-immunisation-providers-regarding-maternal-vaccination-through-the-nip."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2020.09.005","article-title":"The historical aspects of vaccination in pregnancy","volume":"76","author":"Mackin","year":"2021","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","article-title":"The tangled history of mRNA vaccines","volume":"597","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014A new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_49","unstructured":"(2022, April 23). Available online: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-novavax-vaccine-against-covid-19-what%20you%20need-to-know."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"eabh1547","DOI":"10.1126\/sciadv.abh1547","article-title":"A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR Engineering","volume":"7","author":"Zhu","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Batra, H., Zhu, J., Jain, S., Ananthaswamy, N., Mahalingam, M., Tao, P., Lange, C., Zhong, C., Kearny, M.F., and Hu, H. (2021). Engeneeered Bacteriophage T4 Nanoparticle as a Potential Targeted Activator of HIV-1 Latency in CD4+ Human T-Cells. bioRxiv, 453091.","DOI":"10.1101\/2021.07.20.453091"},{"key":"ref_52","unstructured":"Agency, E.M.A. (2022, April 23). Nuvaxoid, EPAR Public Assessment Report 2021. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/nuvaxovid."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S1473-3099(21)00691-5","article-title":"COVID-19 vaccination in pregnancy-number needed to vaccinate to avoid harm","volume":"21","author":"Magee","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_54","unstructured":"European Medicines Agency (2021, July 15). Coronavirus Disease (COVID-19). Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-healththreats\/coronavirus-disease-covid-19."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/AOG.0000000000004290","article-title":"Coronavirus Disease 2019 (COVID-19) vaccines and pregnancy: What obstetricians need to know","volume":"137","author":"Rasmussen","year":"2021","journal-title":"Obstet Gynecol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"n1005","DOI":"10.1136\/bmj.n1005","article-title":"COVID-19: Risk of cerebral blood clots from disease is 10 times that from vaccination, study finds","volume":"373","author":"Torjesen","year":"2021","journal-title":"BMJ"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wilson, R., Paterson, P., and Larson, H.J. (2019). Strategies to improve maternal vaccination acceptance. BMC Public Health, 19.","DOI":"10.1186\/s12889-019-6655-y"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10654-021-00728-6","article-title":"COVID-19 vaccine acceptance among pregnant women and mothers of young children: Results of a survey in 16 countries","volume":"36","author":"Skjefte","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.vaccine.2014.12.062","article-title":"Combined tetanus-diphtheria and pertussis vaccine during pregnancy: Transfer of maternal pertussis antibodies to the newborn","volume":"33","author":"Vilajeliu","year":"2015","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.therap.2021.05.011","article-title":"COVID-19 vaccines and pregnancy: What do we know?","volume":"76","author":"Cottin","year":"2021","journal-title":"Therapie"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bdr2.1696","article-title":"Update on the gestational effects of maternal hyperthermia","volume":"112","author":"Graham","year":"2020","journal-title":"Birth. Defects Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary Findings of mRNA COVID-19 Vaccine Safety in Pregnant Persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"100467","DOI":"10.1016\/j.ajogmf.2021.100467","article-title":"Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy","volume":"3","author":"Theiler","year":"2021","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_64","unstructured":"CDC (2021, November 02). V-safe COVID-19 Vaccine Pregnancy Registry Updated 25 Auguest 2021, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/vsafepregnancyregistry.html."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2021.15494","article-title":"Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy","volume":"326","author":"Kharbanda","year":"2021","journal-title":"JAMA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bpobgyn.2021.02.002","article-title":"Maternal vaccines-safety in pregnancy","volume":"76","author":"Arora","year":"2021","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","article-title":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"303.e1","DOI":"10.1016\/j.ajog.2021.03.023","article-title":"Coronavirus disease 2019 vaccine response in pregnant and lactating women: A cohort study","volume":"225","author":"Gray","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Paul, G., and Chad, R. (2021). Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination\u2014A case report. BMC Pediatr., 21.","DOI":"10.1186\/s12887-021-02618-y"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/AOG.0000000000004367","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Neonatal Cord Blood After Vaccination in Pregnancy","volume":"137","author":"Gill","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Zdanowski, W., and Wa\u015bniewski, T. (2021). Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results. Vaccines, 9.","DOI":"10.22541\/au.162023176.65260617\/v1"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41372-021-01216-1","article-title":"Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy","volume":"41","author":"Lopian","year":"2021","journal-title":"J. Perinatol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Golan, Y., Prahl, M., Cassidy, A.G., Gay, C., Wu, A.H.B., Jigmeddagva, U., Lin, C.Y., Gonzalez, V.J., Basilio, E., and Warrier, L. (2021). COVID-19 mRNA Vaccination in Lactation: Assessment of adverse effects and transfer of anti-SARS-CoV2 antibodies from mother to child. medRxiv.","DOI":"10.1101\/2021.03.09.21253241"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/jama.2021.5782","article-title":"SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women","volume":"325","author":"Perl","year":"2021","journal-title":"JAMA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/08903344211027112","article-title":"The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination","volume":"37","author":"Juncker","year":"2021","journal-title":"J. Hum. Lact."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"101735","DOI":"10.1016\/j.isci.2020.101735","article-title":"Robust and Specific Secretory IgA against SARS-CoV-2 Detected in Human Milk","volume":"23","author":"Fox","year":"2020","journal-title":"iScience"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e03192-20","DOI":"10.1128\/mBio.03192-20","article-title":"Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19","volume":"12","author":"Pace","year":"2021","journal-title":"MBio"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1056\/NEJMc2103916","article-title":"Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for COVID-19","volume":"384","author":"Suthar","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.cell.2021.02.031","article-title":"The multifaceted roles of breast milk antibodies","volume":"184","author":"Atyeo","year":"2021","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Pratama, N.R., Wafa, I.A., Budi, D.S., Putra, M., Wardhana, M.P., and Wungu, C.D.K. (2022). mRNA COVID-19 vaccines in pregnancy: A systematic review. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0261350"},{"key":"ref_81","unstructured":"(2022, April 28). COVID-19: Latest Safety Data Provide Reassurance about Use of mRNA Vaccines during Pregnancy. Available online: https:\/\/www.ema.europa.eu\/en\/news\/covid-19-latest-safety-data-provide-reassurance-about-use-mrna-vaccines-during-pregnancy."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e2121310","DOI":"10.1001\/jamanetworkopen.2021.21310","article-title":"Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout","volume":"4","author":"Kachikis","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2113891","article-title":"Receipt of mRNA COVID-19 Vaccines and Risk of Spontaneous Abortion","volume":"385","author":"Zauche","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1056\/NEJMc2114466","article-title":"COVID-19 Vaccination during Pregnancy and First-Trimester Miscarriage","volume":"385","author":"Magnus","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1016\/j.vaccine.2021.09.012","article-title":"Prenatal maternal COVID-19 vaccination and pregnancy outcomes","volume":"39","author":"Wainstock","year":"2021","journal-title":"Vaccine"},{"key":"ref_86","unstructured":"(2021, October 20). Circolare del Ministero della Salute, Available online: https:\/\/www.trovanorme.salute.gov.it\/norme\/renderNormsanPdf?anno=2021&codLeg=82930&parte=1%20&serie=null."},{"key":"ref_87","unstructured":"(2021, December 20). Position Paper ad Interim SIGO-AOGOI-AGUI-AGITE Shared by SIN\u2014SIP\u2014SIMP\u2014SIERR\u2014FNOPO Vaccinazione Anti-COVID19 e GRAVIDANZA. Available online: https:\/\/www.sin-neonatologia.it\/position-paper-ad-interim-su-vaccinazione-anti-covid19-e-gravidanza\/."},{"key":"ref_88","unstructured":"(2020, December 20). CFD Raccomandazioni Vaccini Donne Incinte e Allattamento, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/pregnancy.html."}],"container-title":["Pediatric Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7503\/14\/2\/34\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:22:01Z","timestamp":1760138521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7503\/14\/2\/34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["pediatric14020034"],"URL":"https:\/\/doi.org\/10.3390\/pediatric14020034","relation":{},"ISSN":["2036-7503"],"issn-type":[{"type":"electronic","value":"2036-7503"}],"subject":[],"published":{"date-parts":[[2022,5,30]]}}}